These findings indicate that enhanced glycolysis contributes to the aggressive tumorigenicity of KMT2D-deficient HNSCC, and the inhibition of glycolysis preferentially impedes the growth of KMT2D-deficient HNSCC cells. Here, KMT2D is linked to head and neck squamous cell carcinoma.